A multicentric study was recently published by Kaiser Permanente and found that ALT screening by AAP guidelines was performed in only 54.0% of children with obesity from 2009 to 2018 (11), indicating that the true incidence of NAFLD is likely not accurate as many patients are likely undiagnosed. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.